http://www.cnr.it/ontology/cnr/individuo/unitaDiPersonaleEsterno/ID1245
NATALE D'ALESSANDRO
- Type
- Label
- NATALE D'ALESSANDRO (literal)
- NATALE D'ALESSANDRO (literal)
- Subject
- Partecipa a commessa
- Persona in rapporto
- Autore CNR di
- Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma. (Articolo in rivista) (Prodotto della ricerca)
- Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Antitumor effects of curcumin and its combination with cisplatin or doxorubicin on hepatic cancer cells: possible relationship to NF-kB activation and IAP gne expression. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combine with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Antitumor effects of curcumin and its combination with cisplatin or doxorubicin on hepatic cancer cells: possible relationship to NF-kB activation and IAP gne expression (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- G. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Cyclooxygenase-2 expression in chronic liver disease and hepatocellular carcinoma: an immunohistochemical study. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells. (Articolo in rivista) (Prodotto della ricerca)
- Sex hormones and risk of liver tumor. (Articolo in rivista) (Prodotto della ricerca)
- Expression of the IAPs in multidrug resistant tumor cells (Articolo in rivista) (Prodotto della ricerca)
- Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of beta-catenin and inhibition of beta-catenin-mediated transactivation (Articolo in rivista) (Prodotto della ricerca)
- Antitumor effects of DHMEQ, a novel NF-kB inhibitor, in human liver cancer cells is mediated through a reactive oxygen species-dependent mechanism. (Articolo in rivista) (Prodotto della ricerca)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Articolo in rivista) (Prodotto della ricerca)
- Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study . (Articolo in rivista) (Prodotto della ricerca)
- Correlation between expression of cyclooxygenase-2 and presence of inflammatory cells in human primary hepatocellular carcinoma: a possible role in tumor promotion and angiogenesis (Articolo in rivista) (Prodotto della ricerca)
- Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combine with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production (Abstract/Poster in convegno) (Prodotto della ricerca)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Cyclooxygenase-2 expression in chronic liver disease and hepatocellular carcinoma: an immunohistochemical study. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Significance of autologous Interleukin 6 production in the HA22T/VGH cell model of hepatocellular carcinoma. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Frequent alteration of the Yin Yang/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- The novel NF-kB inhibitor DHMEQ suppresses the growth of human hepatic cancer cells through redox-dependent signaling. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Significance of autologous Interleukin 6 production in the HA22T/VGH cell model of hepatocellular carcinoma. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Induction of apoptosis and inhibition of cells growth in human hepatocellular carcinoma cells by COX-2 inhibitors. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: possible relationship to the effects on inhibitor of apoptosis protein levels (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Coautore
- Nome
- Cognome
- Afferisce a
- Ha pubblicazioni con
- Http://www.cnr.it/ontology/persone.owl#argomentoDiRicercaSimile
Incoming links:
- Autore CNR
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Antitumor effects of curcumin and its combination with cisplatin or doxorubicin on hepatic cancer cells: possible relationship to NF-kB activation and IAP gne expression. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combine with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Cyclooxygenase-2 expression in chronic liver disease and hepatocellular carcinoma: an immunohistochemical study. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Expression of the IAPs in multidrug resistant tumor cells (Articolo in rivista) (Prodotto della ricerca)
- Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of beta-catenin and inhibition of beta-catenin-mediated transactivation (Articolo in rivista) (Prodotto della ricerca)
- Correlation between expression of cyclooxygenase-2 and presence of inflammatory cells in human primary hepatocellular carcinoma: a possible role in tumor promotion and angiogenesis (Articolo in rivista) (Prodotto della ricerca)
- Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: possible relationship to the effects on inhibitor of apoptosis protein levels (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Induction of apoptosis and inhibition of cells growth in human hepatocellular carcinoma cells by COX-2 inhibitors. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma. (Articolo in rivista) (Prodotto della ricerca)
- Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells. (Articolo in rivista) (Prodotto della ricerca)
- Sex hormones and risk of liver tumor. (Articolo in rivista) (Prodotto della ricerca)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Articolo in rivista) (Prodotto della ricerca)
- Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study . (Articolo in rivista) (Prodotto della ricerca)
- Antitumor effects of DHMEQ, a novel NF-kB inhibitor, in human liver cancer cells is mediated through a reactive oxygen species-dependent mechanism. (Articolo in rivista) (Prodotto della ricerca)
- The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Significance of autologous Interleukin 6 production in the HA22T/VGH cell model of hepatocellular carcinoma. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combine with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production (Abstract/Poster in convegno) (Prodotto della ricerca)
- Frequent alteration of the Yin Yang/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- The novel NF-kB inhibitor DHMEQ suppresses the growth of human hepatic cancer cells through redox-dependent signaling. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Antitumor effects of curcumin and its combination with cisplatin or doxorubicin on hepatic cancer cells: possible relationship to NF-kB activation and IAP gne expression (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- G. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Significance of autologous Interleukin 6 production in the HA22T/VGH cell model of hepatocellular carcinoma. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Cyclooxygenase-2 expression in chronic liver disease and hepatocellular carcinoma: an immunohistochemical study. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Http://www.cnr.it/ontology/persone.owl#argomentoDiRicercaSimile
- Coautore
- Ha pubblicazioni con
- Ha afferente
- Partecipazione di
- Rapporto con persona
- Http://www.w3.org/2004/02/skos/core#isSubjectOf
